Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells

Carcinogenesis

Volumn 19, Issue 3, 1998, Pages 419-424

  Khafif, Avi ^a   Schantz, Stimson P ^a   Chou, Ting Chao ^a   Edelstein, David ^b   Sacks, Peter G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; EPIGALLOCATECHIN GALLATE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CELL CYCLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MITOSIS INHIBITION; MOUTH CANCER; MOUTH MUCOSA; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTICARCINOGENIC AGENTS; CATECHIN; CELLS, CULTURED; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TEA;

EID: 0031927214     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.3.419     Document Type: Article

References (45)

1. Pindborg, J.J. (1985) Oral precancer. In Barnes, L. (ed.) Surgical Pathology of the Head and Neck, Vol. 1. Marcel Dekker, New York, pp. 279-331.
2. Hong, W.K., Lippman, S.M., Itri, L.M., et al. (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323, 795-801.
3. McDonald, S., Haie, C., Rubin, P., Nelson, D. and Rivers, D.L. (1989) Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment and prevention. Int. J. Rad. Oncol. Biol. Phys., 17, 457-465.
4. Cooper, J.S., Pajak, T.F., Rubin, P., Tupchong, L., Brady, L.W., Leibel, S.A., Laramore, G.E., Marcial, V.A., Davis, L.W. and Cox, J.D. (1989) Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int. J. Rad. Oncol. Biol. Phys., 17, 449-456.
5. Benner, S.E., Pajak, T.F., Lippman, S.M., Earley, C. and Hong, W.K. (1994) Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck - long term follow-up. J. Natl Cancer Inst., 86, 140-141.
6. Hong, W.K., Endicott, J., Itri, L.M., et al. (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315, 1501-1505.
7. Yang, C.S. and Wang, Z.-Y. (1993) Tea and cancer. J. Natl Cancer Inst., 85, 1038-1049.
8. Katiyar, S.K., Agarwal, T. and Mukhtak, H. (1992) Green tea in chemoprevention of cancer. Comprehens. Ther., 18, 3-8.
9. Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S.J. and Fujiki, H. (1993) Anti-carcinogenic activity of green tea polyphenols. J. Cancer Res. Clin. Oncol., 23, 186-190.
10. Kono, S., Ikeda, M., Tokudome, S. and Kuratsune, M. (1988) A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jap. J. Cancer Res., 79, 1067-1074.
11. Gao, Y.T., McLaughlin, J.K., Blot, W.J., Ji, B.T., Dai, Q. and Fraumeni, J.F.J. (1994) Reduced risk of esophageal cancer associated with green tea consumption. J. Natl Cancer Inst., 86, 855-858.
12. Mukhopadhay, A., Basu, N., Ghatak, N. and Gujral, P.K. (1982) Antiinflammatory and irritant activity of curcumin analogues in rats. Agents Actions, 12, 508-515.
13. Huang, M.-T., Smart, R.C., Wong, C.-Q. and Conney, A.H. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 48, 5941-5946.
14. Nagabhushan, M. and Bhide, S.V. (1992) Curcumin as an inhibitor of cancer. J. Am. Coll. Nutr., 11, 192-198.
15. Rao, C.V., Simi, B. and Reddy, B.S. (1993) Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in rat colon. Carcinogenesis, 14, 2219-2225.
16. Huang, M.T., Lou, Y.R., Ma, W., Newmark, H.L., Reuhl, K.R. and Conney, A.H. (1994) Inhibitory effects of dietary curcumin on forestomach, duodenum and colon carcinogenesis in mice. Cancer Res., 54, 5841-5847.
17. Mehta, R.G. and Moon, R.C. (1991) Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anticancer Res., 11, 593-596.
18. Kuttan, R., Bhanumathy, P., Nirmala, K. and George, M. (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett., 29, 197-202.
19. Korutla, L. and Kumar, R. (1994) Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta, 1224, 597-600.
20. Kakar, S.S. and Roy, D. (1994) Curcumin inhibits TPA induced expression of c- fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett., 87, 85-89.
21. Liu, J.Y., Lin, S.J. and Lin, J.K. (1993) Inhibitory effects of curcumin on protein kinase activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis, 14, 857-861.
22. Mukundan, M.A., Chacko, M.C., Annapurna, V.V. and Krishnaswamy, K. (1993) Effect of turmeric and curcumin on BP-DNA adducts. Carcinogenesis, 14, 493-496.
23. Helzlsouer, K.J., Block, G., Blumberg, J., Diplock, A.T., Levine, M., Marnett, L.J., Schulplein, R.J., Spence, J.T. and Simic, M.G. (1994) Summary of round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs. Cancer Res. Suppl., 54, 2044s-2051s.
24. Ip, C. (1988) Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection. Cancer Lett., 39, 239-246.
25. Xu, L., Schantz, S.P., Edelstein, D. and Sacks, P.G. (1996) A simplified method for the routine culture of normal oral epithelial (NOE) cells from upper aerodigestive tract mucosa. Methods Cell Sci., 18, 31-39.
26. Sacks, P.G. (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev., 15, 27-51.
27. Sacks, P.G., Parnes, S.M., Gallick, G.E., Mansouri, Z., Lichtner, R., Satya-Prakash, K.L., Pathak, S. and Parsons, D.F. (1988) Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res., 48, 2858-2866.
28. Nusse, M., Beisker, W., Hoffmann, C. and Tarnok, A. (1990) Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements. Cytometry, 11, 813-821.
29. Giaretti, W. and Nusse, M. (1994) Light scatter of isolated cell nuclei as a parameter discriminating the cell cycle compartments. Methods Cell Biol., 41, 389-400.
30. McCaffrey, T.A., Agarwal, L.A. and Weksler, B.B. (1988) A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro. In Vitro Cell. Dev. Biol., 24, 247-252.
31. Chou, T.-C. and Talalay, P. (1984) Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enz. Regul., 22, 27-55.
32. Chou, T.C., Motzer, J.R., Tong, Y. and Bosl, J.G. (1994) Computerized quantitation of synergism and antagonism of taxol, topotecan and cisplatin against teratocarcinoma cell growth: a rational approach to clinical protocol design. J. Natl Cancer Inst., 88, 1517-1524.
33. Chou, T.-C. (1991) The median-effect principle and the combination index for quantitation of synergism and antagonism. In Chou, T.-C. and Rideout, D.C. (eds) Synergism and Antagonism in Chemotherapy. Academic Press, San Diego, pp. 61-102.
34. Chou, J. and Chou, T.-C. (1987) Dose-effect analysis with microcomputers: quantitation of ED50, LD50, synergism, antagonism, low-dose risk, receptor-ligand binding and enzyme kinetics. In Manual and Software for IBM PC. Biosoft, Cambridge, UK.
35. Chou, T.-C. and Hayball M. (1996) Calcusyn for Windows, Multiple-drug Dose- effect Analyser and Manual. Biosoft, Cambridge, UK.
36. Thompson, H.J., Meeker, L.D. and Becci, P.J. (1981) Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res., 41, 1413-1416.
37. Ip, C. and Ip, M.M. (1981) Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vit-A. Carcinogenesis, 2, 915-918.
38. Shklar, G., Schwartz, J., Trickler, D. and Reid, S. (1989) Regression of exprerimental cancer by oral administration of combined alpha-tocopherol and beta-carotene. Nutr. Cancer, 12, 321-325.
39. Schwartz, J.L., Tanaka, V., Khandkar, V., Herman, T.S. and Teicher, B.A. (1992) Beta-carotene and/or vitamine E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemother. Pharmacol., 29, 207-213.
40. Yuspa, S.H. (1994) The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis - Thirty-third G.H.A. Clowes Memorial Award lecture. Cancer Res., 54, 1178-1189.
41. Brooks, S.C.R., Kazmer, S., Levin, A.S. and Yen, A. (1996) Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood, 87, 227-237.
42. Spingarn, A., Sacks, P.G., Kelley, D., Dannenberg, A.J. and Schantz, S.P. (1997) Synergistic effects of 13-cis retinoic acid and arachidonic acid cascade inhibitors on growth of head and neck squamous cell carcinoma in vitro. Otolaryngol. Head Neck Surg., (in press).
43. Kelloff, G.J., Boone, C.W., Crowell, J.A., Steele, V.E., Lubet, R.A., Doody, L.A., Malone, W.E, Hawk, E.T. and Sigman, C.C. (1996) New agents for cancer chemoprevention. J. Cell. Biochem., 26S, 1-28.
44. Yamane, T., Nakatani, H., Kikuoka, N., Mastumoto, H., Iwata, Y., Kitao, Y., Oya, K. and Takahashi, T. (1996) Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer Suppl., 77, 1662-1667.
45. Kelloff, G.J., Boone, C.W., Crowell, J.A., Steele, V.E., Lubet, R. and Sigman, C.C. (1994) Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarker Prev., 3, 85-98.